Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1374.55
28.30
(2.10%)
< Home
< Back
Dr. Reddys Laboratories Ltd. News
>>
Dr. Reddys Laboratories enters into asset purchase agreement with Novartis
>>
Dr. Reddys reports 17% fall in Q2 consolidated net profit
>>
Dr. Reddy’s Laboratories launches Sirolimus tablets in US
>>
FIIs raise stake in Dr Reddy’s Laboratories in September quarter
>>
Dr Reddys Laboratories submits disclosure
>>
Dr Reddys Laboratories submits disclosures
>>
Dr Reddys Laboratories submits disclosures
>>
Dr. Reddys Lab trades higher in late morning deals on BSE
>>
Dr. Reddys gains on launching Levalbuterol Inhalation Solution
>>
Dr. Reddys launches Levalbuterol Inhalation Solution
<<
<
114
115
116
...143
>
>>